THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS
The present invention relates to novel LXR ligands of Formula I and the pharmaceutically acceptable salts, esters and tautomers thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.
-
Page 69
(2010/11/30)
More Articles about upstream products of 652992-47-7